Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CanadaBis Capital Inc V.CANB

Alternate Symbol(s):  CNADF

CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Company’s principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.


TSXV:CANB - Post by User

Post by LorenWibergon Nov 28, 2023 5:49am
137 Views
Post# 35755669

Canadabis /Stigma Grow 2023•Q4 report coming out Nov.28 29

Canadabis /Stigma Grow 2023•Q4 report coming out Nov.28 29 CANB is a very uncommon Canadian Cannabis company.

They have great products, a sharp team and an amazing focus on very high quality product at good prices.

They won "Product of the Year 2023" for their very high potency "Phoenix Tears" drops.

The 2024•Q3 results were awesome, up many hundreds of percent in key areas.

That saw the price rally from around 20cents up to 35 cents Apr-May-June-July.

Currently at 29.5cents Nov 27th, the expected excellent financial results expected should drive a nice climb up and past 35 cents, settling in at 40 to 45 cents.

Perhaps word will get out on this 40 million powerhouse and it will catch on to a larger market.

Typically ownly trading 50,000 to 100,000 shares per days most days so if that gets into the 300,000 to 750,000 shares per day there is gonna be a nice pop.

Loren Wiberg
A happy CANB shareholder since April 2023.
<< Previous
Bullboard Posts
Next >>